New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity
- 1 February 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 127, 379-397
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Synthesis, Characterization and Biological Evaluation of Ureidofibrate-Like Derivatives Endowed with Peroxisome Proliferator-Activated Receptor ActivityJournal of Medicinal Chemistry, 2011
- Mitochondrial Carnitine Palmitoyltransferase 1a (CPT1a) Is Part of an Outer Membrane Fatty Acid Transfer ComplexJournal of Biological Chemistry, 2011
- Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndromeCardiovascular Diabetology, 2011
- Role of Mitochondrial Dysfunction in Insulin ResistanceCirculation Research, 2008
- Statins Activate Human PPARα Promoter and Increase PPARα mRNA Expression and Activation in HepG2 CellsPPAR Research, 2008
- Hydrogen/deuterium‐exchange (H/D‐Ex) of PPARγ LBD in the presence of various modulatorsProtein Science, 2006
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fastingJournal of Clinical Investigation, 1999
- APC mutations occur early during colorectal tumorigenesisNature, 1992